Tipifarnib

Jump to: navigation, search
Tipifarnib
200px
IUPAC name 6-[amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one
Identifiers
CAS number
PubChem 148193
SMILES CN1C=NC=C1C(C2=CC=C(C=C2)Cl) (C3=CC4=C(C=C3)N(C(=O) C=C4C5=CC(=CC=C5)Cl)C)N
Properties
Molecular formula C27H22Cl2N4O
Molar mass 489.39578
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Tipifarnib (Zarnestra) is a drug that is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML).

The compound was discovered by and is under investigation by Johnson & Johnson Pharmaceutical Research & Development, L.L.C, with registration number R115777.



Linked-in.jpg